Cargando…
MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling
BACKGROUND: Chemotherapeutic agents that modulate cell cycle checkpoints and/or tumor-specific pathways have shown immense promise in preclinical and clinical studies aimed at anti-cancer therapy. MASTL (Greatwall in Xenopus and Drosophila), a serine/threonine kinase controls the final G2/M checkpoi...
Autores principales: | Uppada, Srijayaprakash Babu, Gowrikumar, Saiprasad, Ahmad, Rizwan, Kumar, Balawant, Szeglin, Bryan, Chen, Xi, Smith, J. Joshua, Batra, Surinder K., Singh, Amar B., Dhawan, Punita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090950/ https://www.ncbi.nlm.nih.gov/pubmed/30068336 http://dx.doi.org/10.1186/s12943-018-0848-3 |
Ejemplares similares
-
Upregulated Claudin-1 Expression Promotes Colitis-associated Cancer by promoting β-Catenin phosphorylation and activation in Notch/p-AKT Dependent Manner
por: Gowrikumar, Saiprasad, et al.
Publicado: (2019) -
Role of Claudin Proteins in Regulating Cancer Stem Cells and Chemoresistance-Potential Implication in Disease Prognosis and Therapy
por: Gowrikumar, Saiprasad, et al.
Publicado: (2019) -
Loss of Claudin-3 Expression Induces IL6/gp130/Stat3 Signaling to Promote Colon Cancer Malignancy by Hyperactivating Wnt/β-Catenin signaling
por: Ahmad, Rizwan, et al.
Publicado: (2017) -
A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients
por: Gowrikumar, Saiprasad, et al.
Publicado: (2021) -
PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells
por: Kumar, Balawant, et al.
Publicado: (2021)